HCPCS drug code · CMS crosswalk
Enoby HCPCS Code
In short
Enoby is billed under HCPCS Q5167 — Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 1 Enoby NDC under this code.
Reference
- Q5167
- Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mgBilling unit: 1 mg
- Labelers
- Hikma Pharmaceuticals USA Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Added October 2026; 8% of reference add-on applied. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Enoby units and claim line
Enter the dose given to get the Q5167 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Enoby NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9165-01 | Q5167 | Hikma Pharmaceuticals USA Inc. | 1 | 60 |
Enoby: common questions
- What is the HCPCS code for Enoby?
- Enoby is billed under HCPCS Q5167 — Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 1 Enoby NDC under this code.
- How many Q5167 billing units are in a package of Enoby?
- CMS lists 60 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is Q5167 a CPT code?
- No. Q5167 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J0897Injection, denosumab, 1 mg
- Q5136Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
- Q5157Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
- Q5158Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
- Q5159Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
- Q5161Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
- Q5162Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg
- Q5165Injection, denosumab-mobz (oziltus), biosimilar, 1 mg
- Q5166Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg
- Q5171Injection, denosumab-mobz (boncresa), biosimilar, 1 mg